Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02294318 · ClinicalTrials.gov registry record · NA
HealthCall-S: A Pilot Study Targeting Concurrent Non-injection Drug Use and Alcohol in HIV Primary Care Clinics
A NA study, sponsored by Research Foundation for Mental Hygiene.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT02294318: Completed NA study, sponsored by Research Foundation for Mental Hygiene.
NCT02294318 is a NA study that has completed, run by Research Foundation for Mental Hygiene. The registered enrollment target is 47 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02294318, a NA study, has completed, sponsored by Research Foundation for Mental Hygiene.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
This pilot study goal is to compare two different treatments to help HIV positive patients reduce their concurrent drinking and non-injection drug use.
Primary Outcome
This outcome was derived from a Timeline Follow Back (TLFB) completed at the end of the intervention (day 60).
Interventions
- BEHAVIORAL Motivational Interviewing
- BEHAVIORAL HealthCall+Motivational Interviewing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2015-06 |
| Est. Completion | 2016-03 |
| Phase | NA |
What the finished NCT02294318 record still lists
NCT02294318 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Motivational Interviewing is the first listed.
NCT02294318 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02294318 about?
NCT02294318 is a clinical study titled "HealthCall-S: A Pilot Study Targeting Concurrent Non-injection Drug Use and Alcohol in HIV Primary Care Clinics". This pilot study goal is to compare two different treatments to help HIV positive patients reduce their concurrent drinking and non-injection drug use.
What is the current status of trial NCT02294318?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2015-06. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02294318?
The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), HealthCall+Motivational Interviewing (BEHAVIORAL).
Who is sponsoring clinical trial NCT02294318?
This trial is sponsored by Research Foundation for Mental Hygiene, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02294318's enrollment target sits among peer trials
47 1400th of 2000 higher than 599 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia